Try a single issue or save on a subscription Issues delivered straight to your door or device ...

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Sleep apnea affects millions of people worldwide and prevents them from getting quality sleep. It negatively affects patients ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Though past research has focused on the health benefits of cheese, the new data examined its direct relationship to the ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

There is a need for convenient methods for detecting apnea ... individualized treatment. Lisa Strauss, PhD, is a clinical psychologist in the Boston area. She specializes in sleep disorders.

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...